Business Wire

Vivior and SwissLens establish collaboration for the development of personalized contact lenses

2.12.2019 14:56:00 EET | Business Wire | Press release

Share

Both Swiss companies agreed to collaborate in the field of personalized multifocal soft contact lenses for presbyopia correction. The objective is to optimize the design in soft multifocal contact lenses by using the data generated by Vivior’s visual behavior monitor, the Vivior Monitor.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191202005453/en/

“The cooperation with SwissLens represents another milestone for Vivior. With SwissLens we have an established Swiss company as a partner in the growing field of multifocal personalized contact lenses. Both cooperation partners pursue the goal of achieving better vision comfort for customers and patients and complement each other perfectly in terms of technology,” says Andreas Kelch, Sales & Marketing Manager Vision Care at Vivior.

“With Vivior's innovative monitoring system, we obtain objective measurement data of visual behavior that are still unknown today. As a manufacturer of individual lenses, we can incorporate this data into the development of innovative new multifocal lenses. We are pleased about the partnership and the possibly resulting optimized lens designs that should enable the wearer to see better in all areas of vision,” explains Pascal Blaser, Head of Sales and R&D leader at SwissLens.

About SwissLens
Since 1997, SwissLens in Prilly, near Lausanne (Switzerland), has been manufacturing individual contact lenses of the highest quality and distributing them to eye specialists in over 25 countries. Thanks to extensive research, patented and innovative manufacturing technologies, SwissLens is constantly developing its products and services.

www.swisslens.ch

About Vivior
Vivior is a Swiss digital health start-up founded in 2017 by a group of experienced eye care professionals. The company offers a novel wearable device – the Vivior Monitor – to objectively measure visual behavior prior to vision correction interventions. The system collects daily activity data from customers and patients, processes these data in the cloud, and analyzes the lifestyle patterns using machine-learning algorithms. This ground-breaking combination allows to understand better the needs of customers and patients and enables eye care professionals to offer optimal personalized solutions to them. In addition, Vivior develops personalized spectacle, contact and intraocular lenses for vision correction in collaboration with various partners. The goal is to achieve better vision comfort for customers and patients based on the data generated by the Vivior Monitor.
www.vivior.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For more information, please contact:
Vivior AG
Mario Stark, CEO
mario.stark@vivior.com
+41 79 542 88 74

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Tanner Pharma Group and Biodexa Launch Global Early Access Program for FAP Patients31.3.2026 15:00:00 EEST | Press release

Tanner Pharma Group, a global provider of specialty medicine access solutions, and Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing innovative products for gastrointestinal cancers, have announced a strategic partnership to enable global access to eRapa for patients with Familial Adenomatous Polyposis (FAP) through an Early Access / Named Patient Program. FAP is characterized by a proliferation of polyps in the colon and/or rectum, usually occurring in mid-teens. There is no approved therapeutic option, and surgical resection remains the standard of care. eRapa is a proprietary oral capsule formulation of rapamycin (sirolimus), an mTOR inhibitor involved in cellular metabolism, growth, and proliferation and activated during tumorigenesis. mTOR has been shown to be over-expressed in FAP polyps, supporting the rationale for its use in treatment. Through this collaboration, Tanner Pharma will facilitate compliant, controlled access to eRapa

Esri and RoboGarden Sign Strategic MOU to Advance Geospatial and Geomatics Education31.3.2026 15:00:00 EEST | Press release

Esri, the global leader in geographic information system (GIS) technology, today announced the signing of a Memorandum of Understanding (MOU) with RoboGarden Inc. The MOU is aimed at expanding geospatial and geomatics education, improving academic collaboration, and strengthening global workforce readiness. Specifically, this new agreement establishes a framework for Esri and RoboGarden to evaluate new approaches for scalable digital learning, regional responsiveness, and curriculum-aligned academic pathways. The MOU’s four strategic objectives include: creation of a geospatial and geomatics virtual academy, stronger regional execution and responsiveness, academic partnership pathways, and localized esri e-learning opportunities. Organizations across industries will benefit from this initiative, such as business, government agencies, academia, as well as individual learners seeking job-ready skills in GIS. “Esri’s MOU with RoboGarden creates an important opportunity to explore new mode

ExaGrid Named a Finalist for the Network Computing Awards 202631.3.2026 15:00:00 EEST | Press release

ExaGrid®, the world’s largest independent backup storage vendor providing Tiered Backup Storage with the most Comprehensive Security and AI-Powered Retention Time-Lock for Ransomware Recovery, today announced that it has been nominated in 11 categories for the annual Network Computing Awards. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260331887370/en/ ExaGrid has become a finalist in the following categories: Data Protection Product of the Year The Return On Investment Award Air Gapped Ransomware Recovery Product of the Year Storage Product of the Year Hardware Product of the Year The Customer Service Award Enterprise Product of the Year New Product of the Year Product of the Year Company of the Year Additionally, ExaGrid is nominated for the “Bench Tested Product of the Year” award determined by judges after an independent product review of the ExaGrid Tiered Backup Storage SSD and HDD appliances with AI-Powered Retenti

Digital Trust Index 2026: AI Skepticism and Identity Access Friction Are Costing Revenue31.3.2026 15:00:00 EEST | Press release

Thales today released the 2026 Digital Trust Index, one of the most comprehensive global studies of digital trust. Surveying more than 15,000 consumers, business partners, and IT decision makers across 13 industries, the research reveals that digital trust is won or lost during sign-up, login, and throughout the lifecycle of personal data handling. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260331668723/en/ Beyond banking’s clear lead, the rest of the sectors fall well behind in consumer confidence. ©Thales Consumer Trust is Won or Lost at Login For consumers, digital trust often begins at login. Yet, 57% reported problems accessing a website in the past year, and 68% abandoned or switched providers due to slow performance or complicated sign-up processes. When access feels too slow or intrusive, 33% switch to a competitor or abandon the attempt, while 36% delay engagement or look for alternative channels. Consumers are

SLB and Azule Energy Scale Enterprise Digital Operations to Strengthen Energy Delivery in Angola31.3.2026 15:00:00 EEST | Press release

Global technology company SLB (NYSE: SLB) today announced a three-year agreement with Azule Energy to continue and expand the use of its enterprise digital platform across Azule’s operations in Angola. The platform will help Azule drive more consistent execution, accelerate decision-making, and support reliable energy delivery across its portfolio. Azule Energy — a joint venture of bp and Eni and the largest independent energy producer in Angola — operates some of the region’s most complex assets. The agreement builds on two years of Delfi™ use within Azule’s reservoir organization, where the platform supports reservoir studies, modelling, simulation, and well planning workflows, and supports enterprise-scale digital integration by connecting reservoir workflows with broader operational data environments over time. “Azule operates large, complex energy assets where execution reliability and consistency matter,” said ND Maduemezia, president, Europe and Africa, SLB. “This agreement expa

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye